Podcast 171: Repairing Fragmented Care with Value-Based Strategies with Dr. Kamal Golla
ABOUT DR VISHNUKAMAL GOLLA:
Dr. Vishnukamal Golla is the medical director for value transformation at Evolent, a specialty and primary care management company. In this role, Dr. Golla leads the implementation of innovative value-based care models in specialty care. In helping Evolent manage approximately $1 billion of risk-based oncology and cardiology spend, Dr. Golla oversees the development of alternative payment models, prioritizing exceptional patient outcomes through innovative strategies and cost-effective treatment pathways.
Dr. Golla’s research interests include the development and integration of value-based care models, methods of supporting healthcare transformation initiatives at both the state and national level, and the impact of financial toxicity in vulnerable patient populations and caregivers. Past research includes the development of business and policy recommendations to improve specialist engagement with primary care physicians, including design of the specialty strategy for the recently released CMS Innovation Center model called Making Care Primary. Dr. Golla has served as a consultant for the Healthcare Transformation Task force and is also a frequent speaker at value-based care conferences such as the Association for Value-Based Cancer Care to help drive policy recommendations on alternative payment models and specialty alignment.
Dr. Golla received his medical degree and Master of Public Health from the University of Texas Medical School and completed his urologic surgery residency at the University of California, Los Angeles. He completed an advanced fellowship in the Duke University National Clinician Scholars Program, one of the premier health services research and public policy programs in the country. He is also a board-certified and practicing urologist with a deep expertise in urologic oncology, integrating evidence-based practices with value-based care in order to improve care accessibility and quality for all. Dr. Golla maintains a faculty appointment at the Duke University School of Medicine and the Duke Margolis Center for Health Policy.
John Marchica
John Marchica is a veteran health care strategist and CEO of Darwin Research Group. He is leading ongoing, in-depth research initiatives on integrated health systems, accountable care organizations, and value-based care models. He is a faculty associate in the W.P. Carey School of Business and the graduate College of Health Solutions at Arizona State University.
John did his undergraduate work in economics at Knox College, has an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
